Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
Clinical trial NCT04733118 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04733118
- Sponsor
- MedSIR
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2027-03-01
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.